Mid-Term Outcome of Ventricular Arrhythmias Catheter Ablation in Patients with Chronic Coronary Total Occlusion Compared to Ischemic and Non-Ischemic Patients

被引:0
|
作者
Narducci, Maria Lucia [1 ]
Niccoli, Giampaolo [2 ]
Flore, Francesco [1 ]
Perna, Francesco [1 ]
Bencardino, Gianluigi [1 ]
Montone, Rocco Antonio [1 ]
Pelargonio, Gemma [3 ]
Crea, Filippo [3 ]
机构
[1] Fdn Policlin Univ Agostino Gemelli IRCCS, Dipartimento Sci Cardiovascolari, I-00168 Rome, Italy
[2] Univ Parma, Dipartimento Med & Chirurg, I-43125 Parma, Italy
[3] Ist Cardiol Univ Cattolica Sacro Cuore Roma, Dept Cardiovasc Sci, I-00168 Rome, Italy
关键词
personalized medicine; ventricular arrhythmias; radiofrequency catheter ablation; coronary chronic total occlusion; therapeutic strategy; CARDIOVERTER-DEFIBRILLATOR RECIPIENTS; EUROPEAN-SOCIETY; CARDIOLOGY ESC; TASK-FORCE; IMPACT; ASSOCIATION; PREVENTION; GUIDELINES; RECURRENCE; MORTALITY;
D O I
10.3390/jcm11237181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic coronary total occlusions (CTO) are considered an emerging predictor of ventricular arrhythmias (VAs), but currently there are few data on arrhythmic outcomes in patients affected by CTO undergoing radiofrequency catheter ablation of VAs. This study sought to evaluate the impact of unrevascularized CTO on the recurrence of VAs after catheter ablation. This was a single-center retrospective study enrolling 120 patients between 2015 and 2020. All patients were admitted for ventricular tachycardia (VT) or high premature ventricular contractions burden (>25% detected by Holter ECG), without evidence of acute coronary syndrome; they underwent coronary angiography, electrophysiology (EP) study, and three-dimensional electroanatomic mapping (3D-EAM) followed by VAs ablation. Twenty-eight patients (23%) of 120 patients showed CTO at coronary angiography. At baseline, the CTO group presented with higher prevalence of hypertension, chronic renal disease, systolic ventricular dysfunction, secondary prevention ICD implantation, and higher rate of LAVA by 3D-EAM compared with the non-CTO group. At a median follow-up of 15 months (range 1-96 months) after catheter ablation, the only independent predictor of VAs recurrence was the presence of moderate to severe left ventricular (LV) dysfunction. Therefore, the presence of CTO does not predict VAs recurrence after catheter ablation, which is instead predicted by LV dysfunction.
引用
收藏
页数:11
相关论文
共 50 条
  • [11] Relevance of Chronic Total Occlusion for Outcome of Ventricular Tachycardia Ablation in Ischemic Cardiomyopathy
    Lurz, Julia Anna
    Schmidt, Eileen
    Kresoja, Karl-Patrik
    Torri, Federica
    Koenig, Sebastian
    Darma, Angeliki
    Arya, Arash
    Bertagnolli, Livio
    Hindricks, Gerhard
    Dinov, Borislav
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2022, 2022
  • [12] Targeting Ventricular Arrhythmias in Non-Ischemic Patients: Advances in Diagnosis and Treatment
    Stanciulescu, Laura Adina
    Dorobantu, Maria
    Vatasescu, Radu
    DIAGNOSTICS, 2025, 15 (04)
  • [13] Myocardial Fibrosis as a Predictor of Ventricular Arrhythmias in Patients With Non-ischemic Cardiomyopathy
    Schiau, Calin
    Leucuta, Daniel-Corneliu
    Dudea, Sorin Marian
    Manole, Simona
    IN VIVO, 2021, 35 (03): : 1677 - 1685
  • [14] 10-YEAR TRENDS IN CATHETER ABLATION OF ISCHEMIC AND NON-ISCHEMIC VENTRICULAR TACHYCARDIA
    Sutton, Brad
    Nosova, Kristin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 433 - 433
  • [15] Vulnerability for ventricular arrhythmias in patients with chronic coronary total occlusion
    Assaf, Amira
    Diletti, Roberto
    Hoogendijk, Mark G.
    van der Graaf, Marisa
    Zijlstra, Felix
    Szili-Torok, Tamas
    Yap, Sing-Chien
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (08) : 487 - 494
  • [16] Mid-term clinical and hemodynamic outcome following surgical ventricular restoration in patients with ischemic cardiomyopathy
    Di Donato, M
    Castelvecchio, S
    Frigiola, A
    Menicanti, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 245A - 245A
  • [17] Utilization and safety profile of catheter ablation for non-ischemic ventricular tachycardia
    Bhatia, S.
    Patel, P.
    Bhatia, S.
    Arora, S.
    Deshmukh, A.
    EUROPEAN HEART JOURNAL, 2017, 38 : 173 - 173
  • [18] Chronic renal insufficiency is an independent predictor of ventricular arrhythmias and all-cause mortality in ischemic (but not non-ischemic) cardiomyopathy patients
    Chen-Scarabelli, Carol
    Scarabelli, Tiziano M.
    CIRCULATION, 2006, 114 (18) : 651 - 651
  • [19] Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians
    Frontera, Antonio
    Panniker, Sandeep
    Breitenstein, Alexander
    Bruno, Vito Domenico
    Connolly, Georgia May
    Wilson, David
    Rio, Teresa
    Dhinoja, Mehul B.
    Hussain, Wajid
    Schilling, Richard J.
    Thomas, Glyn
    Wong, Tom
    Hunter, Ross J.
    Sacher, Frederic
    Jais, Pierre
    Duncan, Edward
    EUROPACE, 2017, 19 (08): : 1369 - 1377
  • [20] Catheter ablation of ventricular tachycardias in patients with ischemic cardiomyopathy
    Bourier F.
    Busch S.
    Sommer P.
    Maurer T.
    Althoff T.
    Shin D.-I.
    Duncker D.
    Johnson V.
    Estner H.
    Rillig A.
    Bertagnolli L.
    Iden L.
    Deneke T.
    Tilz R.
    Metzner A.
    Chun J.
    Steven D.
    Herzschrittmachertherapie + Elektrophysiologie, 2022, 33 (1) : 88 - 97